Core Laboratories Inc. (CLB) stock
CLBNYSEOil & Gas Field Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/306% above fair value
$8.45+0.06 (+0.72%)
Close on Nov 18, 2026Market cap $387.21MP/E 24.9Yield 0.47%
Core Laboratories free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Core Laboratories's free cash flow for the twelve months ending Sep 30, 2026 was $10.36M, down 72.9% year over year. For fiscal 2025 it was $25.82M, down 42.0% from the year before. The highest annual figure on record is $44.50M in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.82M | -42.0% |
| FY2024 | Dec 31, 2024 | $44.50M | +213.2% |
| FY2023 | Dec 31, 2023 | $14.21M | -3.6% |
| FY2022 | Dec 31, 2022 | $14.74M | -36.0% |
| FY2021 | Dec 31, 2021 | $23.04M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.72M | -73.5% |
| Q2 FY2026 | Jun 30, 2026 | $3.12M | -70.1% |
| Q1 FY2026 | Mar 31, 2026 | $517.00K | -86.7% |
| Q4 FY2025 | Dec 31, 2025 | $5.00M | -71.2% |
| Q3 FY2025 | Sep 30, 2025 | $6.50M | -37.3% |
| Q2 FY2025 | Jun 30, 2025 | $10.45M | -26.8% |
| Q1 FY2025 | Mar 31, 2025 | $3.88M | +56.4% |
| Q4 FY2024 | Dec 31, 2024 | $17.37M | +4.1% |
| Q3 FY2024 | Sep 30, 2024 | $10.37M | – |
| Q2 FY2024 | Jun 30, 2024 | $14.28M | +117.5% |
| Q1 FY2024 | Mar 31, 2024 | $2.48M | – |
| Q4 FY2023 | Dec 31, 2023 | $16.69M | +49.2% |
| Q3 FY2023 | Sep 30, 2023 | -$3.67M | -216.7% |
| Q2 FY2023 | Jun 30, 2023 | $6.57M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.38M | – |
| Q4 FY2022 | Dec 31, 2022 | $11.19M | – |
| Q3 FY2022 | Sep 30, 2022 | $3.15M | – |
See a number that looks wrong?